Search results for "mRNA platform critique"

physician suspension, College investigation, regulatory retaliation claim, excess mortality assertion, mRNA platform critique, immune suppression theory, blood clotting concern, chemotherapy resistance claim, William Makis testified that mRNA vaccines are linked to sudden deaths, aggressive cancers, and immune He asserted that public health authorities ignored early treatment options and that mRNA vaccine technology He expressed concern about ongoing booster campaigns and called for immediate cessation of mRNA vaccine

Witness Testimony Keywords from Transcript virology expertise, viral evolution theory, mRNA platform lipid nanoparticle delivery, biodistribution issues, immune imprinting hypothesis, regulatory oversight critique Appropriateness and Efficacy of the COVID-19 Response in Canada; November 2023 Main Topic Scientific critique One Line Summary Virologist presents concerns about mRNA vaccine platform design, regulatory approval He described the technology as a novel gene-based platform utilizing lipid nanoparticles to deliver genetic

Witness Testimony Keywords from Transcript pharmacotherapeutic assessment, mRNA manufacturing process characterization, contamination impurities, endotoxin risk, CARPA reactions, biodistribution studies critique One Line Summary A pharmacist and drug assessment specialist critiques regulatory classification, manufacturing quality standards, and safety evaluation processes for mRNA COVID-19 vaccines. characterized the regulatory review process as insufficiently rigorous given the novelty and complexity of the platform

vaccine platform, lipid nanoparticle toxicity, pseudouridine modification, immune dysregulation, vitamin Appropriateness and Efficacy of the COVID-19 Response in Canada; November 2023 Main Topic Mechanistic critique regarding vaccine platform safety and immunological consequences. One Line Summary A French CNRS research director presents a biochemical and immunological critique of Regarding mRNA vaccine technology, Dr.

kinase research, spike protein signaling, lipid nanoparticle delivery, biodistribution variability, mRNA pathway dysregulation, adverse event mechanistic theory, genomic integration concern, regulatory review critique analyzes spike protein signaling effects and raises concerns about off-target molecular consequences of mRNA He testified that biodistribution studies indicate the lipid nanoparticle–mRNA complexes may not remain comprehensive molecular pharmacology and long-term safety testing are typically required for novel biologic platforms

Witness Testimony Keywords from Transcript mRNA platform history, lipid nanoparticle inflammation, spike Robert Malone MD Physician and mRNA Technology Researcher Expert Witness ID: NCI-W-040 Hearing Toronto into the Appropriateness and Efficacy of the COVID-19 Response in Canada; November 2023 Main Topic Critique of mRNA vaccine safety, manufacturing quality, pediatric risk–benefit, and allegations of coordinated One Line Summary mRNA pioneer Dr.

microglial activation, long-term neurological risk, precautionary principle advocacy, regulatory oversight critique , experimental platform concerns, adverse event signals Included in the Report: Dr. about spike protein neurotoxicity, biodistribution, and potential long-term neurological effects of mRNA the University of British Columbia, testified regarding potential neurological risks associated with mRNA He stated that novel gene-based platforms should undergo rigorous independent evaluation before widespread

Mechanistic critique of mRNA COVID-19 vaccines based on spike protein interaction with the renin-angiotensin system and concerns regarding vaccine platform safety and immunological consequences. Biochemical critique of mRNA COVID-19 vaccine quality control, spike protein variability, biodistribution Critique of COVID-19 public health policies, vaccine safety, WHO governance, and alleged institutional Scientific critique of mRNA COVID-19 vaccines, allegations of underreported adverse events, institutional

Witness Testimony Keywords from Transcript mRNA integrity variation, spike protein isoforms, translation Appropriateness and Efficacy of the COVID-19 Response in Canada; November 2023 Main Topic Biochemical critique at the Université du Québec à Trois-Rivières, testified regarding the molecular characteristics of mRNA He explained the mechanism of mRNA vaccination, describing how lipid nanoparticles deliver synthetic He stated that published analyses indicated variability in mRNA integrity, with some batches containing

Witness Testimony Keywords from Transcript Pfizer Phase III trial, randomized controlled trial critique analysis of Pfizer’s Phase III mRNA COVID-19 vaccine trial design, data reporting practices, safety Synopsis Deanna McLeod, founder of a medical research analysis firm, presented a detailed critique of Pfizer’s Phase III mRNA COVID-19 vaccine trial, focusing on trial design, data interpretation, and regulatory She also raised concerns about abbreviated safety testing for a novel gene-based platform, including

Witness Testimony Keywords from Transcript mRNA vaccine regulation, gene therapy definition, EMA exclusion -19 Response in Canada; November 2023 Main Topic Regulatory classification and safety evaluation of mRNA One Line Summary A French pharmacist-biologist argues that mRNA COVID-19 vaccines meet definitions of platforms, which involve injection of synthetic genetic material directing host cells to produce spike She argued that, based on definitions from the FDA and European Medicines Agency (EMA), mRNA vaccines

threshold critique, Pfizer adverse effects personal, pediatric vaccination opposition, Réinfo Covid Appropriateness and Efficacy of the COVID-19 Response in Canada; November 2023 Main Topic Scientific critique of mRNA COVID-19 vaccines, allegations of underreported adverse events, institutional censorship, and vaccine side effects, opposition to child vaccination, suspensions for public statements, and argues that mRNA He argued that mRNA vaccines function as pro-drugs with unpredictable biodistribution and spike protein